Solid-state gamma camera developer Digirad of San Diego announced this month that the U.S. Patent Office has granted the company a patent on a method of manufacturing solid-state digital detector modules. Digirad believes the patent is so comprehensive
Solid-state gamma camera developer Digirad of San Diego announced this month that the U.S. Patent Office has granted the company a patent on a method of manufacturing solid-state digital detector modules. Digirad believes the patent is so comprehensive that it will be difficult for other potential solid-state detector manufacturers to avoid infringement.
The patent covers technology that uses semiconductor gamma ray detector modules that can be butted on all sides to form a seamless imaging array of any size. The patent also covers gamma cameras that use these modules, according to the company.
Digirad is unaware of any commercially feasible way to manufacture a solid-state, large field-of-view gamma camera without violating the patent, because solid-state cameras require individual detectors that must be tiled together, rather than a single crystal as used in vacuum-tube systems, according to Karen Klause, president and CEO. Klause declined to comment on whether Digirad would license the buttable module technology.
Digirad manufactures and markets Digirad 2020 TC Imager, a portable single-head gamma camera that uses solid-state detector technology.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.